Non-Coding RNAs in Kidney Stones
Biomolecules · 11.02.2024 · 14 (2) · 213
DOI: 10.3390/biom14020213 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 11.02.2024. Verfasst von Guilin Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Institute of Urology, Gansu Nephro-Urological Clinical Center, Key Laboratory of Urological Diseases in Gansu Province, Lanzho…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Kidney Calculi, MicroRNAs. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cuiying Scientifific and Technological Innovation Program of Lanzhou University Second Hospital, the National Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Nephrolithiasis is a major public health concern associated with high morbidity and recurrence. Despite decades of research, the pathogenesis of nephrolithiasis remains incompletely understood, and effective prevention is lacking. An increasing body of evidence suggests that non-coding RNAs, especially microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), play a role in stone formation and stone-related kidney injury. MiRNAs have been studied quite extensively in nephrolithiasis, and a plethora of specific miRNAs have been implicated in the pathogenesis of nephrolithiasis, involving remarkable changes in calcium metabolism, oxalate metabolism, oxidative stress, cell–crystal adhesion, cellular autophagy, apoptosis, and macrophage (Mp) polarization and metabolism. Emerging evidence suggests a potential for miRNAs as novel diagnostic biomarkers of nephrolithiasis. LncRNAs act as competing endogenous RNAs (ceRNAs) to bind miRNAs, thereby modulating mRNA expression to participate in the regulation of physiological mechanisms in kidney stones. Small interfering RNAs (siRNAs) may provide a novel approach to kidney stone prevention and treatment by treating related metabolic conditions that cause kidney stones. Further investigation into these non-coding RNAs will generate novel insights into the mechanisms of renal stone formation and stone-related renal injury and might lead to new strategies for diagnosing and treating this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Institute of Urology, Gansu Nephro-Urological Clinical Center, Key Laboratory of Urological Diseases in Gansu Province, Lanzhou University Second Hospital, Lanzhou 730030, China.
ORCID-Profile: Guilin Wang
Förderung
- Cuiying Scientifific and Technological Innovation Program of Lanzhou University Second Hospital
- the National Natural Science Foundation of China
- National Natural Science Foundation of China
- Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital
Zitieren
APA
Wang, G., Mi, J., Bai, J., He, Q., Li, X., & Wang, Z. (2024). Non-Coding RNAs in Kidney Stones. Biomolecules, 14(2), 213. https://doi.org/10.3390/biom14020213
Vancouver
Wang G, Mi J, Bai J, He Q, Li X, Wang Z. Non-Coding RNAs in Kidney Stones. Biomolecules. 2024;14(2):213. doi:10.3390/biom14020213
BibTeX
@article{Wang2024,
author = {Wang, Guilin and Mi, Jun and Bai, Jiangtao and He, Qiqi and Li, Xiaoran and Wang, Zhiping},
title = {Non-Coding RNAs in Kidney Stones},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {2},
pages = {213},
doi = {10.3390/biom14020213}
}
EUVIMED